AU3745900A - Methods and compositions for tolerizing hosts for long term survival of tissue transplants - Google Patents

Methods and compositions for tolerizing hosts for long term survival of tissue transplants

Info

Publication number
AU3745900A
AU3745900A AU37459/00A AU3745900A AU3745900A AU 3745900 A AU3745900 A AU 3745900A AU 37459/00 A AU37459/00 A AU 37459/00A AU 3745900 A AU3745900 A AU 3745900A AU 3745900 A AU3745900 A AU 3745900A
Authority
AU
Australia
Prior art keywords
tolerizing
hosts
compositions
methods
long term
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37459/00A
Inventor
Patrick Aebischer
Giovanni Peduto
Christopher Rinsch
Bernard-Laurent Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Isotis SA
Original Assignee
Modex Therapeutiques SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modex Therapeutiques SA filed Critical Modex Therapeutiques SA
Publication of AU3745900A publication Critical patent/AU3745900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
AU37459/00A 1999-03-15 2000-03-15 Methods and compositions for tolerizing hosts for long term survival of tissue transplants Abandoned AU3745900A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12438999P 1999-03-15 1999-03-15
US60124389 1999-03-15
US52482300A 2000-03-14 2000-03-14
US09524823 2000-03-14
PCT/US2000/006737 WO2000054786A1 (en) 1999-03-15 2000-03-15 Methods and compositions for tolerizing hosts for long term survival of tissue transplants

Publications (1)

Publication Number Publication Date
AU3745900A true AU3745900A (en) 2000-10-04

Family

ID=26822527

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37459/00A Abandoned AU3745900A (en) 1999-03-15 2000-03-15 Methods and compositions for tolerizing hosts for long term survival of tissue transplants

Country Status (2)

Country Link
AU (1) AU3745900A (en)
WO (1) WO2000054786A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352883A (en) * 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US5876708A (en) * 1992-02-19 1999-03-02 The General Hospital Corporation Allogeneic and xenogeneic transplantation
ATE422857T1 (en) * 1995-10-26 2009-03-15 Paul P Latta INDUCTION OF IMMUNOLOGICAL TOLERANCE
WO1997041863A1 (en) * 1996-05-09 1997-11-13 The General Hospital Corporation Mixed chimerism and tolerance

Also Published As

Publication number Publication date
WO2000054786A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
AU7389300A (en) Methods of administration of glycopyrrolate compositions
AU2609901A (en) Antimicrobial compositions and methods of use
AU2001249967A1 (en) Composition and methods for tissue preservation
HK1048247B (en) Stable carotene-xanthophyll beadlet compositions and methods of use
AU3347000A (en) Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
AU4661900A (en) Noscapine derivatives as adjuvant compositions and methods of use thereof
AU2001234437A1 (en) Deicing compositions and methods of use
AU2093101A (en) Compositions for efficient release of active ingredients
AU7079700A (en) Improved stable formulations of ace inhibitors, and methods for preparation thereof
AU7358800A (en) Compositions and methods for modification of skin lipid content
AU1261501A (en) Compositions and methods for intranasal delivery of active agents to the brain
AU3632600A (en) Compositions and methods for the treatment of immune related diseases
AU2002216346A1 (en) Cabergoline pharmaceutical compositions and methods of use thereof
AU5487699A (en) Adhesive compositions for the hard tissues of the human body
AU3471400A (en) Compositions and methods for controlled delivery of virus vectors
AU1718301A (en) Use of sugar compositions
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU4228000A (en) Methods and compositions for the treatment and prevention of lung disease
AU1878201A (en) Composition for the treatment of damaged tissue
AU3434601A (en) Compositions and methods for the treatment of immune related diseases
AU4708001A (en) Compositions with low coefficients of friction and methods for their preparation
AU5179800A (en) Mycolactone and related compounds, compositions and methods of use
AU3745900A (en) Methods and compositions for tolerizing hosts for long term survival of tissue transplants
AU2002303552A1 (en) Methods and compositions for prevention of angioproliferation
AU2002364911A1 (en) Dmt-tic di- and tri-peptidic derivatives and related compositions and methods of use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase